Why the study?
The association between coronary physiological progression and clinical outcomes had not been investigated.
Does total physiological atherosclerotic burden and its progression assessed by serial 3V-QFR predict major adverse cardiovascular events in patients with coronary artery disease?
Cohort (n=421)
No
Does total physiological atherosclerotic burden and its progression assessed by serial 3V-QFR predict major adverse cardiovascular events in patients with coronary artery disease?
Total physiological atherosclerotic burden and its progression, assessed by serial 3V-QFR, provide incremental prognostic value over clinical characteristics for predicting MACE in patients with coronary artery disease.
Answers are grounded in this paper and cite their sources.
Serial 3V-QFR may refine MACE risk stratification in CAD; hypothesis-generating and requires prospective validation before practice change.
The association between coronary physiological progression and clinical outcomes has not been investigated. A total of 421 patients who underwent serial coronary angiography at least 6 months apart were included. Total physiological atherosclerotic burden was characterized by sum of quantitative flow ratio in 3 epicardial vessels (3V-QFR). The relationships of the 3V-QFR and its longitudinal change (Δ3V-QFR) with major adverse cardiovascular events (MACE) were explored. 3V-QFR values derived from follow-up angiograms were slightly lower compared to baseline (2.85 [2.77, 2.90] vs. 2.86 [2.80, 2.90], p < 0.001). The median Δ3V-QFR value was −0.01 (−0.05, 0.02). The multivariable models demonstrated follow-up 3V-QFR or Δ3V-QFR were independently associated with MACE (both p < 0.05). Patients with both low follow-up 3V-QFR (≤ 2.78) and low Δ3V-QFR (≤ −0.05) presented 3 times higher risk of MACE than those without (hazard ratio: 2.953, 95% confidence interval 1.428-6.104, p = 0.003). Furthermore, adding patient-level 3V-QFR and Δ3V-QFR to clinical model significantly improved the predictability for MACE. In conclusion, total physiological atherosclerotic burden and its progression can provide incremental prognostic value over clinical characteristics, supporting the use of coronary physiology in the evaluation of disease progression and for the identification of vulnerable patients.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2023) conducted a cohort in Coronary artery disease (n=421). Low follow-up 3V-QFR (≤ 2.78) and low △3V-QFR (≤ -0.05) vs. High follow-up 3V-QFR and high △3V-QFR was evaluated on Major adverse cardiovascular events (MACE), a composite of cardiac death, non-fatal MI, or ischemia-driven revascularization (HR 2.953, 95% CI 1.428-6.104, p=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: